RAPGEF1 and breast cancer: Several lines of evidence also support a tumor suppressor role for C3G in cancer development and progression, playing a negative role in invasion and metastasis in breast cancer [7], CRC [4], HCC [5], and GBM [6], with the latter also showing reduced proliferation.